CN102215846A - D-核糖用于疲劳对象的用途 - Google Patents

D-核糖用于疲劳对象的用途 Download PDF

Info

Publication number
CN102215846A
CN102215846A CN2009801324503A CN200980132450A CN102215846A CN 102215846 A CN102215846 A CN 102215846A CN 2009801324503 A CN2009801324503 A CN 2009801324503A CN 200980132450 A CN200980132450 A CN 200980132450A CN 102215846 A CN102215846 A CN 102215846A
Authority
CN
China
Prior art keywords
ribose
effective amount
fatigue
subjects
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2009801324503A
Other languages
English (en)
Chinese (zh)
Inventor
J·A·圣塞尔
D·J·麦卡特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioenergy Inc
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Priority to CN201510527242.0A priority Critical patent/CN105232564A/zh
Publication of CN102215846A publication Critical patent/CN102215846A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Medicinal Preparation (AREA)
CN2009801324503A 2008-08-20 2009-08-20 D-核糖用于疲劳对象的用途 Pending CN102215846A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510527242.0A CN105232564A (zh) 2008-08-20 2009-08-20 D-核糖用于改善心肺功能的用途

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18949808P 2008-08-20 2008-08-20
US61/189498 2008-08-20
US20812209P 2009-02-20 2009-02-20
US61/208122 2009-02-20
PCT/US2009/004738 WO2010021713A1 (en) 2008-08-20 2009-08-20 Use of d-ribose for fatigued subjects

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510527242.0A Division CN105232564A (zh) 2008-08-20 2009-08-20 D-核糖用于改善心肺功能的用途

Publications (1)

Publication Number Publication Date
CN102215846A true CN102215846A (zh) 2011-10-12

Family

ID=41172394

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2009801324503A Pending CN102215846A (zh) 2008-08-20 2009-08-20 D-核糖用于疲劳对象的用途
CN201510527242.0A Pending CN105232564A (zh) 2008-08-20 2009-08-20 D-核糖用于改善心肺功能的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510527242.0A Pending CN105232564A (zh) 2008-08-20 2009-08-20 D-核糖用于改善心肺功能的用途

Country Status (8)

Country Link
US (2) US20100189785A1 (enExample)
EP (1) EP2323668A1 (enExample)
JP (2) JP2012500261A (enExample)
CN (2) CN102215846A (enExample)
AU (1) AU2009283215B2 (enExample)
BR (1) BRPI0917360A2 (enExample)
CA (1) CA2734769A1 (enExample)
WO (1) WO2010021713A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102488669A (zh) * 2011-12-30 2012-06-13 上海希迪制药有限公司 一种改善d-核糖引湿性的方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009123742A1 (en) * 2008-04-02 2009-10-08 St Cyr John A Use of ribose in first response to acute myocardial infarction
HK1243944A1 (zh) * 2014-11-03 2018-07-27 Bioenergy Life Science, Inc. 使用d-核糖增强对躯体应激的适应性
WO2017120731A1 (en) * 2016-01-11 2017-07-20 Shanghai Yao Yuan Biotechnology Co., Ltd. Methods and compositions for reducing body weight
JP6542687B2 (ja) 2016-01-28 2019-07-10 日本特殊陶業株式会社 ガスセンサユニット
US10434113B2 (en) 2016-12-16 2019-10-08 The Charlotte Mecklenburg Hospital Authority Compositions and methods for treating muscular dystrophy and other disorders
US20190313682A1 (en) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet
WO2020041750A1 (en) * 2018-08-24 2020-02-27 The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health Methods and compositions for treating disorders associated with muscle weakness
KR102435548B1 (ko) * 2022-05-31 2022-08-26 (주)에이피테크놀로지 액상스틱형 에너지 스포츠 음료

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
EP1745789A1 (en) * 1998-06-19 2007-01-24 Bioenergy Inc. Compositions comprising ribose for increasing energy in vivo
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
EP1095658A3 (en) * 1999-10-27 2002-10-23 Bioenergy Inc. Use of ribose to treat fibromyalgia
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
WO2005089774A1 (en) * 2004-03-18 2005-09-29 Tanabe Seiyaku Co., Ltd. D-ribose for improving depression-like symptoms
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
US20050277598A1 (en) * 2004-04-29 2005-12-15 Maccarter Dean J Method for improving ventilatory efficiency
US7645742B2 (en) * 2005-06-22 2010-01-12 Advocare International, L.P. Composition for enhancing cellular energy
JPWO2022123637A1 (enExample) 2020-12-07 2022-06-16

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102488669A (zh) * 2011-12-30 2012-06-13 上海希迪制药有限公司 一种改善d-核糖引湿性的方法

Also Published As

Publication number Publication date
EP2323668A1 (en) 2011-05-25
AU2009283215A2 (en) 2011-05-12
BRPI0917360A2 (pt) 2015-11-17
US20120264701A1 (en) 2012-10-18
US20100189785A1 (en) 2010-07-29
AU2009283215A1 (en) 2010-02-25
WO2010021713A1 (en) 2010-02-25
JP2016014009A (ja) 2016-01-28
AU2009283215B2 (en) 2014-12-04
CN105232564A (zh) 2016-01-13
CA2734769A1 (en) 2010-02-25
JP2012500261A (ja) 2012-01-05

Similar Documents

Publication Publication Date Title
CN102215846A (zh) D-核糖用于疲劳对象的用途
EP1087779B1 (en) Compositions for increasing energy in vivo
KR20110135986A (ko) 당뇨병 요법을 지원하기 위한 α-케토산을 포함하는 식이 보충제
US20190275065A1 (en) Method for improving ventilatory efficiency
Do Amaral et al. The effect of acute magnesium loading on the maximal exercise performance of stable chronic obstructive pulmonary disease patients
Marzorati et al. Exercise testing in late-onset glycogen storage disease type II patients undergoing enzyme replacement therapy
AU2016311131B2 (en) Mineral compositions for stimulating the carbohydrate metabolism
Kressler et al. Sildenafil does not improve steady state cardiovascular hemodynamics, peak power, or 15-km time trial cycling performance at simulated moderate or high altitudes in men and women
US20240075000A1 (en) Treatment of pathological fatigue with oxaloacetate
US20160317561A1 (en) Use of d-ribose for fatigued subjects
EP1745789A1 (en) Compositions comprising ribose for increasing energy in vivo
Roelofs et al. The effects of pomegranate extract on anaerobic exercise performance & cardiovascular responses
JP2025079108A (ja) 心理的負荷がかかった健常者の精神状態の改善をするための組成物及び方法
KR20170082568A (ko) 신체적 스트레스에 대한 순응을 증진시키기 위한 d-리보오스의 용도
Vitti et al. Combined ketone ester and carbohydrate solution on exercise capacity in type 2 diabetics
Heusser et al. Nutrition with ‘light and water’? In strict isolation for 10 days without food–a critical case study
Szabóová et al. Can the Regular Physical Load Change the Functional State of Pupils in Elementary School?
CN101264093A (zh) 用于增加体内能量的组合物
Jones THE INFLUENCE OF A HIGH-NITRATE BEVERAGE ON THE RATE OF FORCE DEVELOPMENT AND PEAK FORCE OUTPUT OF COLLEGE-AGED INDIVIDUALS DURING AN ISOMETRIC MID-THIGH PULL
NZ740091B2 (en) Mineral compositions for stimulating the carbohydrate metabolism
Wright The effects of cardiorespiratory fitness and exercise intensity on blood glucose concentrations in individuals with non-insulin dependent diabetes mellitus
Colson The concomitant effects of cordyceps sinensis supplementation on physiological performance indices during cycling in males
Derosier The effects of varying postexercise nutrition on subsequent exercise performance in active adults habitually consuming a low-carbohydrate/high-fat diet
Ruiz The effect of an aerobic exercise program and two hypocaloric diets of different carbohydrate content on blood pressure and sodium balance in obese females
So-Eun et al. The Effect of Circadian Rhythm on Post Exercise Energy Metabolism and Circulatory Response

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: BIOENERGY LIFE SCIENCE, INC.

Free format text: FORMER OWNER: BIOENERGY INC.

Effective date: 20150814

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20150814

Address after: American Minnesota

Applicant after: BIOENERGY, INC

Address before: American Minnesota

Applicant before: Bioenergy Inc.

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20111012